1. Home
  2. PCB vs SGHT Comparison

PCB vs SGHT Comparison

Compare PCB & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PCB Bancorp

PCB

PCB Bancorp

HOLD

Current Price

$21.85

Market Cap

307.0M

Sector

Finance

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$6.20

Market Cap

395.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCB
SGHT
Founded
2003
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.0M
395.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PCB
SGHT
Price
$21.85
$6.20
Analyst Decision
Hold
Buy
Analyst Count
2
8
Target Price
$24.50
$8.23
AVG Volume (30 Days)
20.7K
340.7K
Earning Date
01-27-2026
03-04-2026
Dividend Yield
3.60%
N/A
EPS Growth
43.50
N/A
EPS
2.41
N/A
Revenue
$107,743,000.00
$76,052,000.00
Revenue This Year
$21.55
N/A
Revenue Next Year
$8.65
$12.07
P/E Ratio
$9.21
N/A
Revenue Growth
13.61
N/A
52 Week Low
$16.00
$2.03
52 Week High
$24.04
$9.24

Technical Indicators

Market Signals
Indicator
PCB
SGHT
Relative Strength Index (RSI) 47.89 31.24
Support Level $21.50 $6.39
Resistance Level $22.79 $7.55
Average True Range (ATR) 0.50 0.55
MACD 0.02 -0.21
Stochastic Oscillator 42.43 8.66

Price Performance

Historical Comparison
PCB
SGHT

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Share on Social Networks: